메뉴 건너뛰기




Volumn 191, Issue 5, 2013, Pages 2514-2525

Protection against tuberculosis with homologous or heterologous protein/vector vaccine approaches is not dependent on CD8+ T cells

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BCG VACCINE; GAMMA INTERFERON; GLUCOSE DERIVATIVE; IMMUNOLOGICAL ADJUVANT; LIVE VACCINE; PLACEBO; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN ID93; UNCLASSIFIED DRUG;

EID: 84883427666     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301161     Document Type: Article
Times cited : (25)

References (59)
  • 1
    • 0026539069 scopus 로고
    • Tuberculosis: A global overview of the situation today
    • Sudre, P., G. ten Dam, and A. Kochi. 1992. Tuberculosis: a global overview of the situation today. Bull. World Health Organ. 70: 149-159.
    • (1992) Bull. World Health Organ. , vol.70 , pp. 149-159
    • Sudre, P.1    Ten Dam, G.2    Kochi, A.3
  • 2
    • 84935892144 scopus 로고    scopus 로고
    • WHO. World Health Organization, Geneva
    • WHO. 2012. Global Tuberculosis Report 2012. World Health Organization, Geneva.
    • (2012) Global Tuberculosis Report 2012
  • 3
    • 22944433876 scopus 로고    scopus 로고
    • The success and failure of BCG: Implications for a novel tuberculosis vaccine
    • Andersen, P., and T. M. Doherty. 2005. The success and failure of BCG: implications for a novel tuberculosis vaccine. Nat. Rev. Microbiol. 3: 656-662.
    • (2005) Nat. Rev. Microbiol. , vol.3 , pp. 656-662
    • Andersen, P.1    Doherty, T.M.2
  • 7
    • 84857482098 scopus 로고    scopus 로고
    • The importance of adjuvant formulation in the development of a tuberculosis vaccine
    • Baldwin, S. L., S. Bertholet, V. A. Reese, L. K. Ching, S. G. Reed, and R. N. Coler. 2012. The importance of adjuvant formulation in the development of a tuberculosis vaccine. J. Immunol. 188: 2189-2197.
    • (2012) J. Immunol. , vol.188 , pp. 2189-2197
    • Baldwin, S.L.1    Bertholet, S.2    Reese, V.A.3    Ching, L.K.4    Reed, S.G.5    Coler, R.N.6
  • 9
    • 84871839521 scopus 로고    scopus 로고
    • IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection
    • Green, A. M., R. Difazio, and J. L. Flynn. 2013. IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection. J. Immunol. 190: 270-277.
    • (2013) J. Immunol. , vol.190 , pp. 270-277
    • Green, A.M.1    Difazio, R.2    Flynn, J.L.3
  • 11
    • 0037106372 scopus 로고    scopus 로고
    • Human dendritic cells presenting adenovirally expressed antigen elicit Mycobacterium tuberculosis-specific CD8+ T cells
    • Lewinsohn, D. A., R. A. Lines, and D. M. Lewinsohn. 2002. Human dendritic cells presenting adenovirally expressed antigen elicit Mycobacterium tuberculosis-specific CD8+ T cells. Am. J. Respir. Crit. Care Med. 166: 843-848.
    • (2002) Am. J. Respir. Crit. Care Med. , vol.166 , pp. 843-848
    • Lewinsohn, D.A.1    Lines, R.A.2    Lewinsohn, D.M.3
  • 15
    • 33845595414 scopus 로고    scopus 로고
    • Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis
    • Bennekov, T., J. Dietrich, I. Rosenkrands, A. Stryhn, T. M. Doherty, and P. Andersen. 2006. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis. Eur. J. Immunol. 36: 3346-3355.
    • (2006) Eur. J. Immunol. , vol.36 , pp. 3346-3355
    • Bennekov, T.1    Dietrich, J.2    Rosenkrands, I.3    Stryhn, A.4    Doherty, T.M.5    Andersen, P.6
  • 16
    • 65249121913 scopus 로고    scopus 로고
    • CD4 and CD8 T cell responses to the M tuberculosis Ag85B-TB104 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination
    • Elvang, T., J. P. Christensen, R. Billeskov, T. Thi Kim Thanh Hoang, P. Holst, A. R. Thomsen, P. Andersen, and J. Dietrich. 2009. CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination. PLoS One 4: e5139.
    • (2009) PLoS One , vol.4
    • Elvang, T.1    Christensen, J.P.2    Billeskov, R.3    Hoang, T.T.K.T.4    Holst, P.5    Thomsen, A.R.6    Andersen, P.7    Dietrich, J.8
  • 17
    • 56849108004 scopus 로고    scopus 로고
    • RBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector
    • Magalhaes, I., D. R. Sizemore, R. K. Ahmed, S. Mueller, L. Wehlin, C. Scanga, F. Weichold, G. Schirru, M. G. Pau, J. Goudsmit, et al. 2008. rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector. PLoS One 3: e3790.
    • (2008) PLoS One , vol.3
    • Magalhaes, I.1    Sizemore, D.R.2    Ahmed, R.K.3    Mueller, S.4    Wehlin, L.5    Scanga, C.6    Weichold, F.7    Schirru, G.8    Pau, M.G.9    Goudsmit, J.10
  • 18
    • 80054004840 scopus 로고    scopus 로고
    • Tuberculosis vaccine promises sterilizing immunity
    • McShane, H., and A. Williams. 2011. Tuberculosis vaccine promises sterilizing immunity. Nat. Med. 17: 1185-1186.
    • (2011) Nat. Med. , vol.17 , pp. 1185-1186
    • McShane, H.1    Williams, A.2
  • 19
    • 84864758568 scopus 로고    scopus 로고
    • A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants
    • Odutola, A. A., O. A. Owolabi, P. K. Owiafe, H. McShane, and M. O. Ota. 2012. A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants. Vaccine 30: 5591-5594.
    • (2012) Vaccine , vol.30 , pp. 5591-5594
    • Odutola, A.A.1    Owolabi, O.A.2    Owiafe, P.K.3    McShane, H.4    Ota, M.O.5
  • 21
    • 77949532239 scopus 로고    scopus 로고
    • Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection
    • Ronan, E. O., L. N. Lee, P. C. Beverley, and E. Z. Tchilian. 2009. Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection. PLoS One 4: e8235.
    • (2009) PLoS One , vol.4
    • Ronan, E.O.1    Lee, L.N.2    Beverley, P.C.3    Tchilian, E.Z.4
  • 22
    • 79957584452 scopus 로고    scopus 로고
    • Tuberculosis vaccines in clinical trials
    • Rowland, R., and H. McShane. 2011. Tuberculosis vaccines in clinical trials. Expert Rev. Vaccines 10: 645-658.
    • (2011) Expert Rev. Vaccines , vol.10 , pp. 645-658
    • Rowland, R.1    McShane, H.2
  • 23
    • 33746632535 scopus 로고    scopus 로고
    • Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis
    • Santosuosso, M., S. McCormick, X. Zhang, A. Zganiacz, and Z. Xing. 2006. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis. Infect. Immun. 74: 4634-4643.
    • (2006) Infect. Immun. , vol.74 , pp. 4634-4643
    • Santosuosso, M.1    McCormick, S.2    Zhang, X.3    Zganiacz, A.4    Xing, Z.5
  • 24
    • 8444222278 scopus 로고    scopus 로고
    • Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis
    • Wang, J., L. Thorson, R. W. Stokes, M. Santosuosso, K. Huygen, A. Zganiacz, M. Hitt, and Z. Xing. 2004. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J. Immunol. 173: 6357-6365.
    • (2004) J. Immunol. , vol.173 , pp. 6357-6365
    • Wang, J.1    Thorson, L.2    Stokes, R.W.3    Santosuosso, M.4    Huygen, K.5    Zganiacz, A.6    Hitt, M.7    Xing, Z.8
  • 25
    • 67649236987 scopus 로고    scopus 로고
    • Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis
    • Xing, Z., C. T. McFarland, J. M. Sallenave, A. Izzo, J. Wang, and D. N. McMurray. 2009. Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis. PLoS One 4: e5856.
    • (2009) PLoS One , vol.4
    • Xing, Z.1    McFarland, C.T.2    Sallenave, J.M.3    Izzo, A.4    Wang, J.5    McMurray, D.N.6
  • 26
    • 84855444592 scopus 로고    scopus 로고
    • Rare serotype adenoviral vectors for HIV vaccine development
    • Michael, N. L. 2012. Rare serotype adenoviral vectors for HIV vaccine development. J. Clin. Invest. 122: 25-27.
    • (2012) J. Clin. Invest. , vol.122 , pp. 25-27
    • Michael, N.L.1
  • 27
    • 80053371681 scopus 로고    scopus 로고
    • Viruses: From pathogens to vaccine carriers
    • Small, J. C., and H. C. Ertl. 2011. Viruses: from pathogens to vaccine carriers. Curr. Opin. Virol. 1: 241-245.
    • (2011) Curr. Opin. Virol. , vol.1 , pp. 241-245
    • Small, J.C.1    Ertl, H.C.2
  • 28
    • 84873028543 scopus 로고    scopus 로고
    • Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors
    • Tan, W. G., H. T. Jin, E. E. West, P. Penaloza-MacMaster, A. Wieland, M. J. Zilliox, M. J. McElrath, D. H. Barouch, and R. Ahmed. 2013. Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors. J. Virol. 87: 1359-1372.
    • (2013) J. Virol. , vol.87 , pp. 1359-1372
    • Tan, W.G.1    Jin, H.T.2    West, E.E.3    Penaloza-MacMaster, P.4    Wieland, A.5    Zilliox, M.J.6    McElrath, M.J.7    Barouch, D.H.8    Ahmed, R.9
  • 30
    • 84875382846 scopus 로고    scopus 로고
    • Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial
    • MVA85A 020 Trial Study Team
    • Tameris, M. D., M. Hatherill, B. S. Landry, T. J. Scriba, M. A. Snowden, S. Lockhart, J. E. Shea, J. B. McClain, G. D. Hussey, W. A. Hanekom, et al; MVA85A 020 Trial Study Team. 2013. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 381: 1021-1028.
    • (2013) Lancet , vol.381 , pp. 1021-1028
    • Tameris, M.D.1    Hatherill, M.2    Landry, B.S.3    Scriba, T.J.4    Snowden, M.A.5    Lockhart, S.6    Shea, J.E.7    McClain, J.B.8    Hussey, G.D.9    Hanekom, W.A.10
  • 31
    • 77955517246 scopus 로고    scopus 로고
    • Novel adenovirus vector-based vaccines for HIV-1
    • Barouch, D. H. 2010. Novel adenovirus vector-based vaccines for HIV-1. Curr. Opin. HIV AIDS 5: 386-390.
    • (2010) Curr. Opin. HIV AIDS , vol.5 , pp. 386-390
    • Barouch, D.H.1
  • 34
    • 80054003999 scopus 로고    scopus 로고
    • Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVAB) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)
    • García, F., J. C. Bernaldo de Quirós, C. E. Gómez, B. Perdiguero, J. L. Nájera, V. Jiménez, J. García-Arriaza, A. C. Guardo, I. Pérez, V. Díaz-Brito, et al. 2011. Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVAB) in healthy HIV-1-uninfected volunteers: a phase I clinical trial (RISVAC02). Vaccine 29: 8309-8316.
    • (2011) Vaccine , vol.29 , pp. 8309-8316
    • García, F.1    Bernaldo De Quirós, J.C.2    Gómez, C.E.3    Perdiguero, B.4    Nájera, J.L.5    Jiménez, V.6    García-Arriaza, J.7    Guardo, A.C.8    Pérez, I.9    Díaz-Brito, V.10
  • 35
    • 84860337949 scopus 로고    scopus 로고
    • DNA and modified vaccinia virus Ankara vaccines encoding multiple cytotoxic and helper T-lymphocyte epitopes of human immunodeficiency virus type 1 (HIV-1) are safe but weakly immunogenic in HIV-1-uninfected, vaccinia virus-naive adults
    • Gorse, G. J., M. J. Newman, A. deCamp, C. M. Hay, S. C. De Rosa, E. Noonan, B. D. Livingston, J. D. Fuchs, S. A. Kalams, and F. L. Cassis-Ghavami; NIAID HIV Vaccine Trials Network. 2012. DNA and modified vaccinia virus Ankara vaccines encoding multiple cytotoxic and helper T-lymphocyte epitopes of human immunodeficiency virus type 1 (HIV-1) are safe but weakly immunogenic in HIV-1-uninfected, vaccinia virus-naive adults. Clin. Vaccine Immunol. 19: 649-658.
    • (2012) Clin. Vaccine Immunol. , vol.19 , pp. 649-658
    • Gorse, G.J.1    Newman, M.J.2    Decamp, A.3    Hay, C.M.4    De Rosa, S.C.5    Noonan, E.6    Livingston, B.D.7    Fuchs, J.D.8    Kalams, S.A.9    Cassis-Ghavami, F.L.10
  • 36
    • 84857399087 scopus 로고    scopus 로고
    • Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors
    • Sheehy, S. H., C. J. Duncan, S. C. Elias, S. Biswas, K. A. Collins, G. A. O'Hara, F. D. Halstead, K. J. Ewer, T. Mahungu, A. J. Spencer, et al. 2012. Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors. PLoS One 7: e31208.
    • (2012) PLoS One , vol.7
    • Sheehy, S.H.1    Duncan, C.J.2    Elias, S.C.3    Biswas, S.4    Collins, K.A.5    O'Hara, G.A.6    Halstead, F.D.7    Ewer, K.J.8    Mahungu, T.9    Spencer, A.J.10
  • 39
    • 77958498605 scopus 로고    scopus 로고
    • Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa
    • Jaoko, W., E. Karita, K. Kayitenkore, G. Omosa-Manyonyi, S. Allen, S. Than, E. M. Adams, B. S. Graham, R. A. Koup, R. T. Bailer, et al. 2010. Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa. PLoS One 5: e12873.
    • (2010) PLoS One , vol.5
    • Jaoko, W.1    Karita, E.2    Kayitenkore, K.3    Omosa-Manyonyi, G.4    Allen, S.5    Than, S.6    Adams, E.M.7    Graham, B.S.8    Koup, R.A.9    Bailer, R.T.10
  • 40
    • 77749322238 scopus 로고    scopus 로고
    • Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses
    • VRC 009 Study Team; VRC 010 Study Team
    • Koup, R. A., M. Roederer, L. Lamoreaux, J. Fischer, L. Novik, M. C. Nason, B. D. Larkin, M. E. Enama, J. E. Ledgerwood, R. T. Bailer, et al; VRC 009 Study Team; VRC 010 Study Team. 2010. Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses. PLoS One 5: e9015.
    • (2010) PLoS One , vol.5
    • Koup, R.A.1    Roederer, M.2    Lamoreaux, L.3    Fischer, J.4    Novik, L.5    Nason, M.C.6    Larkin, B.D.7    Enama, M.E.8    Ledgerwood, J.E.9    Bailer, R.T.10
  • 42
    • 0030971268 scopus 로고    scopus 로고
    • HLA-A2.1-restricted education and cytolytic activity of CD8 (+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice
    • Pascolo, S., N. Bervas, J. M. Ure, A. G. Smith, F. A. Lemonnier, and B. Pérarnau. 1997. HLA-A2.1-restricted education and cytolytic activity of CD8 (+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J. Exp. Med. 185: 2043-2051.
    • (1997) J. Exp. Med. , vol.185 , pp. 2043-2051
    • Pascolo, S.1    Bervas, N.2    Ure, J.M.3    Smith, A.G.4    Lemonnier, F.A.5    Pérarnau, B.6
  • 45
    • 77950643077 scopus 로고    scopus 로고
    • Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis
    • Henao-Tamayo, M. I., D. J. Ordway, S. M. Irwin, S. Shang, C. Shanley, and I. M. Orme. 2010. Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis. Clin. Vaccine Immunol. 17: 618-625.
    • (2010) Clin. Vaccine Immunol. , vol.17 , pp. 618-625
    • Henao-Tamayo, M.I.1    Ordway, D.J.2    Irwin, S.M.3    Shang, S.4    Shanley, C.5    Orme, I.M.6
  • 46
    • 22344433382 scopus 로고    scopus 로고
    • Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin
    • Grode, L., P. Seiler, S. Baumann, J. Hess, V. Brinkmann, A. Nasser Eddine, P. Mann, C. Goosmann, S. Bandermann, D. Smith, et al. 2005. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin. J. Clin. Invest. 115: 2472-2479.
    • (2005) J. Clin. Invest. , vol.115 , pp. 2472-2479
    • Grode, L.1    Seiler, P.2    Baumann, S.3    Hess, J.4    Brinkmann, V.5    Nasser Eddine, A.6    Mann, P.7    Goosmann, C.8    Bandermann, S.9    Smith, D.10
  • 47
    • 0032574807 scopus 로고    scopus 로고
    • Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes
    • Hess, J., D. Miko, A. Catic, V. Lehmensiek, D. G. Russell, and S. H. Kaufmann. 1998. Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes. Proc. Natl. Acad. Sci. USA 95: 5299-5304.
    • (1998) Proc. Natl. Acad. Sci. USA , vol.95 , pp. 5299-5304
    • Hess, J.1    Miko, D.2    Catic, A.3    Lehmensiek, V.4    Russell, D.G.5    Kaufmann, S.H.6
  • 48
    • 80054745408 scopus 로고    scopus 로고
    • Recombinant BCG DureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses
    • Desel, C., A. Dorhoi, S. Bandermann, L. Grode, B. Eisele, and S. H. Kaufmann. 2011. Recombinant BCG DureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses. J. Infect. Dis. 204: 1573-1584.
    • (2011) J. Infect. Dis. , vol.204 , pp. 1573-1584
    • Desel, C.1    Dorhoi, A.2    Bandermann, S.3    Grode, L.4    Eisele, B.5    Kaufmann, S.H.6
  • 49
    • 84870546622 scopus 로고    scopus 로고
    • The recombinant tuberculosis vaccine rBCG DureC:Hly(+) induces apoptotic vesicles for improved priming of CD4(+) and CD8(+) T cells
    • Farinacci, M., S. Weber, and S. H. Kaufmann. 2012. The recombinant tuberculosis vaccine rBCG DureC:hly(+) induces apoptotic vesicles for improved priming of CD4(+) and CD8(+) T cells. Vaccine 30: 7608-7614.
    • (2012) Vaccine , vol.30 , pp. 7608-7614
    • Farinacci, M.1    Weber, S.2    Kaufmann, S.H.3
  • 50
    • 0034610299 scopus 로고    scopus 로고
    • Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model
    • Horwitz, M. A., G. Harth, B. J. Dillon, and S. Maslesa-Galic'. 2000. Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc. Natl. Acad. Sci. USA 97: 13853-13858.
    • (2000) Proc. Natl. Acad. Sci. USA , vol.97 , pp. 13853-13858
    • Horwitz, M.A.1    Harth, G.2    Dillon, B.J.3    Maslesa-Galic, S.4
  • 52
    • 84872616132 scopus 로고    scopus 로고
    • Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis
    • Waeckerle-Men, Y., N. Bruffaerts, Y. Liang, F. Jurion, P. Sander, T. M. Kündig, K. Huygen, and P. Johansen. 2013. Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis. Vaccine 31: 1057-1064.
    • (2013) Vaccine , vol.31 , pp. 1057-1064
    • Waeckerle-Men, Y.1    Bruffaerts, N.2    Liang, Y.3    Jurion, F.4    Sander, P.5    Kündig, T.M.6    Huygen, K.7    Johansen, P.8
  • 53
    • 0345269791 scopus 로고    scopus 로고
    • Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virusinfected mice
    • Johnson, B. J., E. O. Costelloe, D. R. Fitzpatrick, J. B. Haanen, T. N. Schumacher, L. E. Brown, and A. Kelso. 2003. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virusinfected mice. Proc. Natl. Acad. Sci. USA 100: 2657-2662.
    • (2003) Proc. Natl. Acad. Sci. USA , vol.100 , pp. 2657-2662
    • Johnson, B.J.1    Costelloe, E.O.2    Fitzpatrick, D.R.3    Haanen, J.B.4    Schumacher, T.N.5    Brown, L.E.6    Kelso, A.7
  • 54
    • 17844387159 scopus 로고    scopus 로고
    • Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection
    • Lawrence, C. W., R. M. Ream, and T. J. Braciale. 2005. Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection. J. Immunol. 174: 5332-5340.
    • (2005) J. Immunol. , vol.174 , pp. 5332-5340
    • Lawrence, C.W.1    Ream, R.M.2    Braciale, T.J.3
  • 55
    • 80052309163 scopus 로고    scopus 로고
    • Long-term humoral and cellular immune responses elicited by a heterologous Plasmodium vivax apical membrane antigen 1 protein prime/adenovirus boost immunization protocol
    • Bouillet, L. E., M. O. Dias, N. A. Dorigo, A. D. Moura, B. Russell, F. Nosten, L. Renia, E. M. Braga, R. T. Gazzinelli, M. M. Rodrigues, et al. 2011. Long-term humoral and cellular immune responses elicited by a heterologous Plasmodium vivax apical membrane antigen 1 protein prime/adenovirus boost immunization protocol. Infect. Immun. 79: 3642-3652.
    • (2011) Infect. Immun. , vol.79 , pp. 3642-3652
    • Bouillet, L.E.1    Dias, M.O.2    Dorigo, N.A.3    Moura, A.D.4    Russell, B.5    Nosten, F.6    Renia, L.7    Braga, E.M.8    Gazzinelli, R.T.9    Rodrigues, M.M.10
  • 56
    • 84856189784 scopus 로고    scopus 로고
    • Robust immune response elicited by a novel and unique Mycobacterium tuberculosis protein using an optimized DNA/protein heterologous prime/boost protocol
    • Cayabyab, M. J., S. S. Kashino, and A. Campos-Neto. 2012. Robust immune response elicited by a novel and unique Mycobacterium tuberculosis protein using an optimized DNA/protein heterologous prime/boost protocol. Immunology 135: 216-225.
    • (2012) Immunology , vol.135 , pp. 216-225
    • Cayabyab, M.J.1    Kashino, S.S.2    Campos-Neto, A.3
  • 58
    • 34248329578 scopus 로고    scopus 로고
    • Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone
    • Stewart, V. A., S. M. McGrath, P. M. Dubois, M. G. Pau, P. Mettens, J. Shott, M. Cobb, J. R. Burge, D. Larson, L. A. Ware, et al. 2007. Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone. Infect. Immun. 75: 2283-2290.
    • (2007) Infect. Immun. , vol.75 , pp. 2283-2290
    • Stewart, V.A.1    McGrath, S.M.2    Dubois, P.M.3    Pau, M.G.4    Mettens, P.5    Shott, J.6    Cobb, M.7    Burge, J.R.8    Larson, D.9    Ware, L.A.10
  • 59
    • 84865436912 scopus 로고    scopus 로고
    • CD4+ T cell-dependent IFN-γ production by CD8+ effector T cells in Mycobacterium tuberculosis infection
    • Bold, T. D., and J. D. Ernst. 2012. CD4+ T cell-dependent IFN-γ production by CD8+ effector T cells in Mycobacterium tuberculosis infection. J. Immunol. 189: 2530-2536.
    • (2012) J. Immunol. , vol.189 , pp. 2530-2536
    • Bold, T.D.1    Ernst, J.D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.